Company Filing History:
1 out of 1 
1 out of 2 Years Active: 2023
Title: Zhepeng Wei: Innovator in Pharmaceutical Chemistry
Introduction
Zhepeng Wei is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications.
Latest Patents
Zhepeng Wei holds a patent for "Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors." This invention provides a method for preparing a pyrrolopyrimidine compound and its applications. Specifically, it includes a compound represented by formula I or its pharmaceutically acceptable salts, a pharmaceutical composition containing the compound or its salts, and a method for preparing the pharmaceutical composition. The application of this pharmaceutical composition is as an immunosuppressive drug.
Career Highlights
Throughout his career, Zhepeng Wei has worked with several companies, including Cinakate Pharm Tech (Shanghai) Co., Ltd. and Cinkate Pharmaceutical Intermediates Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical technology and drug development.
Collaborations
Zhepeng Wei has collaborated with notable coworkers such as Na Liu and Lixia Bao. Their combined efforts have furthered research and innovation in the pharmaceutical sector.
Conclusion
Zhepeng Wei's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as an innovator in the field. His work continues to impact the development of new medical therapies.